MAPT and Mental deterioration: This not only highlights the value of multimodal PET and DCE-MRI studies to complement established disease biomarkers (e.g. Aβ, tau, DAT-PET, cognitive decline, structural MRI, etc.), but also emphasizes the importance of studying BBB and inflammatory mechanisms in tandem.